In patients with FMF, it significantly reduces circulating endothelial markers like asymmetric dimethylarginine (ADMA), thrombomodulin (TM), and osteoprotegerin (OPG), clearly reflecting its endothelial protective properties [37]. The gene discussed is THBD; the disease is familial Mediterranean fever.